Tumor treating fields may improve the prognosis of patients with lung cancer brain metastases

被引：0
作者：
Peng, Junsong [1 ,2 ]
Zhang, Liyang [3 ]
Wu, Yinghua [1 ,2 ]
Chen, Ling [4 ]
Liu, Zhixiong [1 ,2 ]
Liu, Fangkun [1 ,2 ]
Zeng, Yu [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Reg Ctr Neurol Dis, Dept Neurosurg, Nanchang, Jiangxi, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, Beijing 100853, Peoples R China
来源：
BRAIN STIMULATION | 2025年 / 18卷 / 03期
基金：
中国国家自然科学基金;
关键词：
THERAPY;
D O I：
10.1016/j.brs.2025.03.003
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：707 / 709
页数：3
相关论文
共 50 条
  • [31] Gamma knife radiosurgery for multiple brain metastases from lung cancer
    Park, Seong-Hyun
    Hwang, Sung-Kyoo
    Kang, Dong-Hun
    Lee, Sun-Ho
    Park, Jaechan
    Hwang, Jeong-Hyun
    Hamm, In-Suk
    Park, Yeun-Mook
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (05) : 626 - 629
  • [32] Metastatic differentiated thyroid cancer: worst prognosis in patients with metachronous metastases
    Gonzalez-Clavijo, Angelica Maria
    Cuellar, Andres A.
    Triana-Urrego, Jenny
    Barrero, Jorge A.
    Fierro-Maya, Luis Felipe
    [J]. ENDOCRINE, 2023, 81 (01) : 90 - 97
  • [33] Tumor treating fields can effectively overcome trastuzumab resistant breast cancer multiplication
    Kim, Jin Su
    Cho, Jae Min
    Kim, Hyeongi
    Jeong, Youn Kyoung
    Kim, Jong-Ki
    Kim, Eun Ho
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (08): : 3935 - +
  • [34] Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor
    Amin, Saber
    Baine, Michael J.
    Meza, Jane L.
    Lin, Chi
    [J]. JAMA NETWORK OPEN, 2020, 3 (09)
  • [35] Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?
    Park, Byeong-Bae
    Uhm, Ji Eun
    Cho, Eun Yoon
    La Choi, Yoon
    Ji, Sang Hoon
    Nam, Do Hyun
    Lee, Jung Il
    Park, Won
    Huh, Seung Jae
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 627 - 633
  • [36] Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases
    Chen, Kaiyan
    Yu, Xiaoqing
    Zhang, Fanrong
    Xu, Yanjun
    Zhang, Peng
    Huang, Zhiyu
    Fan, Yun
    [J]. LUNG CANCER, 2018, 125 : 8 - 13
  • [37] Fucosylated α1-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer
    Yokobori, Takehiko
    Yazawa, Shin
    Asao, Takayuki
    Nakazawa, Nobuhiro
    Mogi, Akira
    Sano, Rie
    Kuwano, Hiroyuki
    Kaira, Kyoichi
    Shirabe, Ken
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases
    Lauko, Adam
    Kotecha, Rupesh
    Barnett, Addison
    Li, Hong
    Tatineni, Vineeth
    Ali, Assad
    Patil, Pradnya
    Mohammadi, Alireza M.
    Chao, Samuel T.
    Murphy, Erin S.
    Angelov, Lilyana
    Suh, John H.
    Barnett, Gene H.
    Pennell, Nathan A.
    Ahluwalia, Manmeet S.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
    Porta, R.
    Sanchez-Torres, J. M.
    Paz-Ares, L.
    Massuti, B.
    Reguart, N.
    Mayo, C.
    Lianes, P.
    Queralt, C.
    Guillem, V.
    Salinas, P.
    Catot, S.
    Isla, D.
    Pradas, A.
    Gurpide, A.
    de Castro, J.
    Polo, E.
    Puig, T.
    Taron, M.
    Colomer, R.
    Rosell, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 624 - 631
  • [40] Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
    Zheng, Lie
    Xie, Hui
    Luo, Xiao
    Yang, Yadi
    Zhang, Yijun
    Li, Yue
    Yin, Shaohan
    Li, Hui
    Xie, Chuanmiao
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345